1
Hudziak Robert M, Shepard H Michael, Ullrich Axel: Domaine extracellulaire de her2, Her2 extracellular domain. Genentech, Genentech, GOWLING LAFLEUR HENDERSON, November 29, 1990: CA2055441 (6 worldwide citation)

An extracellular portion of the HER2 molecule, essentially free of transmembrane and cytoplasmic portions, which is anti-genic in animals. Isolated DNA encoding the extracellular portion; an expression vector containing the isolated DNA; and a cellcontaining the expression vector. A process for prod ...


2
Buck Stephen H, Herman Richard M, Porreca Frank: Composition and method for neural desensitization. Afferon Corporation, ROSENBAUM David G, November 29, 1990: WO/1990/014083 (4 worldwide citation)

The invention consists of a composition and method for desensitizing sensory neurons by administration of therapeutic amounts of resiniferatoxin.


3
Huse William D: Method for isolating receptors having a preselected specificity. Scripps Clinic And Research Foundation, BINGHAM Douglas A, November 29, 1990: WO/1990/014424 (3 worldwide citation)

The present invention relates to a method for isolating from a repertoire of genes containing a conserved nucleotide sequence a gene coding for a receptor having a preselected activity. Receptors produced by the gene isolated by the method, particularly catalytic receptors, are also contemplated.


4
Huse William D: Co-expression of heteromeric receptors. Huse William D, PERRYMAN David, November 29, 1990: WO/1990/014443 (3 worldwide citation)

The invention provides a composition of matter comprising a plurality of procaryotic cells containing diverse combinations of first and second DNA sequences encoding first and second polypeptides that can be expressed and which form heteromeric receptors and at least one of the plurality of procaryo ...


5
Herbranson Dale E, Rosenberg Leonard S, Speicher Earl R: Stable pharmaceutical composition of 3-(hydroxymethyl)-5,5-diphenylhydantoin disodium phosphate ester. The Du Pont Merck Pharmaceutical Company, FATO Gildo E, November 29, 1990: WO/1990/014080 (2 worldwide citation)

Described is a stable pharmaceutical composition of 3-(hydroxymethyl)-5,5-diphenylhydantoin disodium phosphate ester, the produg of 5,5-diphenylhydantoin (phenytoin) a commonly used drug for the treatment and management of epilepsy and other types of convulsive states. It has been found that degrada ...


6
Kowligi Rajagopal R, Farnan Robert Charles, Colone William Michael, Della, Corna Linda V, Sinnott Joseph Brian: Non-porous coated ptfe graft. Impra, November 29, 1990: WO/1990/014054 (1 worldwide citation)

A non-porous coated PTFE graft (20) includes a PTFE tube (32) having a conventional porous inner cylindrical wall (34) and a non-porous elastomeric coating (38) applied over at least a portion of the outer cylindrical wall (36) of the PTFE tube to render such portion of the outer cylindrical wall no ...


7
Penillard Philippe, Penillard Aimée: (Fr) Dispositif modulaire a circulation de liquide, notamment jeu de construction a eau, (En) Modular liquid-circulating device, especially for use in constructional toys with water flows. Penillard Philippe, Penillard Aimée, PLAÇAIS Jean Yves, November 29, 1990: WO/1990/014142 (1 worldwide citation)

(EN) The modular device includes a container (1) which can hold a liquid, and support means (5) which can be joined to the container in such a way as to form with it a structure of which a part is raised above the level of the liquid held in the container and which has a first assembly pattern. The ...


8
Fergason James L, Ning Sun C Fan, Buck Jesse David: High speed optical protection using smectic liquid crystal. Optical Shields, CAMPBELL Jay R, November 29, 1990: WO/1990/014611 (1 worldwide citation)

An optical limiter (10) includes smectic liquid crystal (12) between a bounding media (16, 14) the liquid crystal being aligned in layers (22a, b, etc.) which are oriented generally perpendicularly with respect to the media. Preferably such media comprise respective surfaces (18, 20).


9
Mcclennen William H, Arnold Neil S, Meuzelaar Henk L C: Apparatus and method for sampling. University Of Utah, HESS Andrew C, November 29, 1990: WO/1990/014587 (1 worldwide citation)

The system operates by inducing a sample to flow into an outer chamber (22) and excluding the sample from an inner chamber (18) having an inner chamber orifice (11) located within the outer chamber by inducing a first pressure zone in the inner chamber such that a substantially discrete interface be ...


10
Lerner Richard A, Sorge Joseph A: A new method for tapping the immunological repertoire. Scripps Clinic And Research Foundation, Stratagene, BINGHAM Douglas A, November 29, 1990: WO/1990/014430 (1 worldwide citation)

The present invention relates to a method for isolating from the immunological gene repertoire a gene coding for a receptor having the ability to bind a preselected ligand. Receptors produced by the gene isolated by the method, particularly catalytic receptors, are also contemplated.